324 related articles for article (PubMed ID: 32299492)
21. 14-3-3 Proteins Reduce Cell-to-Cell Transfer and Propagation of Pathogenic α-Synuclein.
Wang B; Underwood R; Kamath A; Britain C; McFerrin MB; McLean PJ; Volpicelli-Daley LA; Whitaker RH; Placzek WJ; Becker K; Ma J; Yacoubian TA
J Neurosci; 2018 Sep; 38(38):8211-8232. PubMed ID: 30093536
[TBL] [Abstract][Full Text] [Related]
22. The absence of reactive astrocytosis is indicative of a unique inflammatory process in Parkinson's disease.
Mirza B; Hadberg H; Thomsen P; Moos T
Neuroscience; 2000; 95(2):425-32. PubMed ID: 10658622
[TBL] [Abstract][Full Text] [Related]
23. Immunological features of alpha-synuclein in Parkinson's disease.
Roodveldt C; Christodoulou J; Dobson CM
J Cell Mol Med; 2008 Oct; 12(5B):1820-9. PubMed ID: 18671754
[TBL] [Abstract][Full Text] [Related]
24. The role of glia in Parkinson's disease: Emerging concepts and therapeutic applications.
Kuter KZ; Cenci MA; Carta AR
Prog Brain Res; 2020; 252():131-168. PubMed ID: 32247363
[TBL] [Abstract][Full Text] [Related]
25. Antigen-presenting cell diversity for T cell reactivation in central nervous system autoimmunity.
Waisman A; Johann L
J Mol Med (Berl); 2018 Dec; 96(12):1279-1292. PubMed ID: 30386908
[TBL] [Abstract][Full Text] [Related]
26. Relative efficiency of microglia, astrocytes, dendritic cells and B cells in naive CD4+ T cell priming and Th1/Th2 cell restimulation.
Aloisi F; Ria F; Columba-Cabezas S; Hess H; Penna G; Adorini L
Eur J Immunol; 1999 Sep; 29(9):2705-14. PubMed ID: 10508245
[TBL] [Abstract][Full Text] [Related]
27. Calpain in the cleavage of alpha-synuclein and the pathogenesis of Parkinson's disease.
Shams R; Banik NL; Haque A
Prog Mol Biol Transl Sci; 2019; 167():107-124. PubMed ID: 31601400
[TBL] [Abstract][Full Text] [Related]
28. NACP/alpha-synuclein-positive filamentous inclusions in astrocytes and oligodendrocytes of Parkinson's disease brains.
Wakabayashi K; Hayashi S; Yoshimoto M; Kudo H; Takahashi H
Acta Neuropathol; 2000 Jan; 99(1):14-20. PubMed ID: 10651022
[TBL] [Abstract][Full Text] [Related]
29. Picomolar concentrations of oligomeric alpha-synuclein sensitizes TLR4 to play an initiating role in Parkinson's disease pathogenesis.
Hughes CD; Choi ML; Ryten M; Hopkins L; Drews A; Botía JA; Iljina M; Rodrigues M; Gagliano SA; Gandhi S; Bryant C; Klenerman D
Acta Neuropathol; 2019 Jan; 137(1):103-120. PubMed ID: 30225556
[TBL] [Abstract][Full Text] [Related]
30. Immune responses in the Parkinson's disease brain.
Weiss F; Labrador-Garrido A; Dzamko N; Halliday G
Neurobiol Dis; 2022 Jun; 168():105700. PubMed ID: 35314321
[TBL] [Abstract][Full Text] [Related]
31. Toxoplasma gondii inhibits MHC class II expression in neural antigen-presenting cells by down-regulating the class II transactivator CIITA.
Lüder CG; Lang C; Giraldo-Velasquez M; Algner M; Gerdes J; Gross U
J Neuroimmunol; 2003 Jan; 134(1-2):12-24. PubMed ID: 12507768
[TBL] [Abstract][Full Text] [Related]
32. The deficiency of NRSF/REST enhances the pro-inflammatory function of astrocytes in a model of Parkinson's disease.
Li H; Liu Z; Wu Y; Chen Y; Wang J; Wang Z; Huang D; Wang M; Yu M; Fei J; Huang F
Biochim Biophys Acta Mol Basis Dis; 2020 Jan; 1866(1):165590. PubMed ID: 31706914
[TBL] [Abstract][Full Text] [Related]
33. Pathological role of lipid interaction with α-synuclein in Parkinson's disease.
Suzuki M; Sango K; Wada K; Nagai Y
Neurochem Int; 2018 Oct; 119():97-106. PubMed ID: 29305919
[TBL] [Abstract][Full Text] [Related]
34. B7/BB-1 antigen expression on adult human microglia studied in vitro and in situ.
Williams K; Ulvestad E; Antel JP
Eur J Immunol; 1994 Dec; 24(12):3031-7. PubMed ID: 7528666
[TBL] [Abstract][Full Text] [Related]
35. CIITA expression is regulated by histone deacetylase enzymes and has a role in α-synuclein pre-formed fibril-induced antigen presentation in murine microglial cell line.
Günaydın C; Çelik ZB; Bilge SS
Immunopharmacol Immunotoxicol; 2022 Jun; 44(3):447-455. PubMed ID: 35291899
[TBL] [Abstract][Full Text] [Related]
36. α‑synuclein induces apoptosis of astrocytes by causing dysfunction of the endoplasmic reticulum‑Golgi compartment.
Liu M; Qin L; Wang L; Tan J; Zhang H; Tang J; Shen X; Tan L; Wang C
Mol Med Rep; 2018 Jul; 18(1):322-332. PubMed ID: 29749529
[TBL] [Abstract][Full Text] [Related]
37. Exosomes of BV-2 cells induced by alpha-synuclein: important mediator of neurodegeneration in PD.
Chang C; Lang H; Geng N; Wang J; Li N; Wang X
Neurosci Lett; 2013 Aug; 548():190-5. PubMed ID: 23792198
[TBL] [Abstract][Full Text] [Related]
38. Differential expression of B7 co-stimulatory molecules by astrocytes correlates with T cell activation and cytokine production.
Soos JM; Ashley TA; Morrow J; Patarroyo JC; Szente BE; Zamvil SS
Int Immunol; 1999 Jul; 11(7):1169-79. PubMed ID: 10383950
[TBL] [Abstract][Full Text] [Related]
39. E46K mutant α-synuclein is more degradation resistant and exhibits greater toxic effects than wild-type α-synuclein in Drosophila models of Parkinson's disease.
Sakai R; Suzuki M; Ueyama M; Takeuchi T; Minakawa EN; Hayakawa H; Baba K; Mochizuki H; Nagai Y
PLoS One; 2019; 14(6):e0218261. PubMed ID: 31242217
[TBL] [Abstract][Full Text] [Related]
40. Targeting of the class II transactivator attenuates inflammation and neurodegeneration in an alpha-synuclein model of Parkinson's disease.
Williams GP; Schonhoff AM; Jurkuvenaite A; Thome AD; Standaert DG; Harms AS
J Neuroinflammation; 2018 Aug; 15(1):244. PubMed ID: 30165873
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
